{
    "Additional Indicators": [
        {
            "description": "Unfavorable Prognosis",
            "therapy": "NCCN, Consensus, Non-Small Cell Lung Cancer",
            "mutation": "KRASp.G12C Gain-of-function"
        }
    ],
    "Clinical trials": [
        {
            "description": "A Study of VS-6766 v. VS-6766 + Defactinib in Recurrent G12V, Other KRAS and BRAF Non-Small Cell Lung Cancer ",
            "phase": "Phase 2",
            "mutations": [
                "KRAS"
            ]
        },
        {
            "description": "A Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1",
            "phase": "Phase 1/2",
            "mutations": [
                "KRAS",
                "STK11"
            ]
        },
        {
            "description": "First-in-human Study of DRP-104 (Sirpiglenastat) as Single Agent and in Combination With Atezolizumab in Patients With Advanced Solid Tumors. (NCT04471415)",
            "phase": "Phase 1/2",
            "mutations": [
                "NFE2L2",
                "STK11"
            ]
        }
    ],
    "variants of unknown significance": {
        "Somatic": [
            {
                "Gene": "IKZF1",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.N159Y Nonsense-GOF",
                "VariantAlleleFraction": "13.64%"
            },
            {
                "Gene": "RNF43",
                "DNA Alteration": "c.954G>T",
                "GeneMutation": "p.A169T Nonsense-LOF",
                "VariantAlleleFraction": "17.84%"
            },
            {
                "Gene": "CHD6",
                "DNA Alteration": "c.4800C>G",
                "GeneMutation": "p.I1600M Nonsense-GOF",
                "VariantAlleleFraction": "9.95%"
            },
            {
                "Gene": "IKZF1",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.N159Y Nonsense-LOF",
                "VariantAlleleFraction": "1.41%"
            },
            {
                "Gene": "HSD3B1",
                "DNA Alteration": "c.1100C>A",
                "GeneMutation": "p.T367= Frameshift-GOF",
                "VariantAlleleFraction": "2.03%"
            },
            {
                "Gene": "MAP2K2",
                "DNA Alteration": "c.383C>T",
                "GeneMutation": "p.P128L Nonsense-LOF",
                "VariantAlleleFraction": "4.35%"
            },
            {
                "Gene": "GNAS",
                "DNA Alteration": "c.374A>G",
                "GeneMutation": "p.R201S Nonsense-LOF",
                "VariantAlleleFraction": "9.04%"
            },
            {
                "Gene": "MYO1G",
                "DNA Alteration": "c.145G>A",
                "GeneMutation": "p.V49M Frameshift-GOF",
                "VariantAlleleFraction": "9.62%"
            }
        ],
        "Germline": [
            {
                "Gene": "CTNNB1",
                "DNA Alteration": "c.97T>C",
                "GeneMutation": "p.S45P Stopgain-LOF",
                "Condition": "technology"
            },
            {
                "Gene": "TP53",
                "DNA Alteration": "c.638G>A",
                "GeneMutation": "p.V272A Nonsense-LOF",
                "Condition": "rise"
            }
        ]
    }
}